{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T18:09:45Z","timestamp":1765994985723,"version":"3.37.3"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>Since 2017, an increasing number of opioid overdoses in Oslo, Norway, has been categorized as involving unspecified opioids, as noted in the patient records by the doctor treating the patient. In this study we compare the characteristics of overdoses involving unspecified opioids, long-acting opioids, and heroin. Data on patients presenting with opioid overdose was retrospectively collected from 1 October 2013 to 31 December 2019 at the Oslo Accident and Emergency Outpatient Clinic.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among 2381 included cases, 459 (19.3%) involved unspecified opioids, 134 (5.6%) long-acting opioids, and 1788 (75.1%) heroin. Overdoses involving unspecified opioids needed longer observation, median 5\u00a0h 29\u00a0min vs. 4\u00a0h 54\u00a0min (long-acting opioids) and 4\u00a0h 49\u00a0min (heroin) (p\u2009&lt;\u20090.001), and had a lower Glasgow coma scale score, median 10 vs. 13 in both the other groups (p\u2009&lt;\u20090.001). Naloxone was given in 23.3% of cases involving unspecified opioids, vs. 12.7% involving long-acting opioids and 30.2% involving heroin (p\u2009&lt;\u20090.001). A larger proportion of patients were transferred to hospital care when unspecified or long-acting opioids were involved compared to heroin, 16.3% and 18.7% respectively vs. 10.1% (p\u2009&lt;\u20090.001). Our results indicate that the category \u201cunspecified opioids\u201d encompasses a substantial proportion of opioids acting longer than heroin.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13104-022-06022-2","type":"journal-article","created":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T08:02:40Z","timestamp":1649491360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Unspecified opioids among opioid overdoses in Oslo, Norway"],"prefix":"10.1186","volume":"15","author":[{"given":"Zahra Zeineb","family":"Iqbal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanh Mai Thi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mette","family":"Brekke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1213-392X","authenticated-orcid":false,"given":"Odd Martin","family":"Vallersnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,9]]},"reference":[{"key":"6022_CR1","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). European drug report 2020: trends and developments. Lisbon, Portugal: EMCDDA; 2020."},{"key":"6022_CR2","unstructured":"Centers for Disease Control and Prevention (CDC). Understanding the epidemic. CDC. 2020. https:\/\/www.cdc.gov\/drugoverdose\/epidemic\/index.html. Accessed 2 Feb 2021."},{"key":"6022_CR3","doi-asserted-by":"publisher","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","volume":"69","author":"N Wilson","year":"2020","unstructured":"Wilson N, Kariisa M, Seth P, Smith H, Davis NL. Drug and opioid-involved overdose deaths: United States, 2017\u20132018. MMWR Morb Mortal Wkly Rep. 2020;69:290\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"6022_CR4","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1056\/NEJMra1202561","volume":"367","author":"EW Boyer","year":"2012","unstructured":"Boyer EW. Management of opioid analgesic overdose. N Engl J Med. 2012;367:146\u201355.","journal-title":"N Engl J Med"},{"key":"6022_CR5","doi-asserted-by":"publisher","first-page":"584","DOI":"10.7326\/0003-4819-130-7-199904060-00019","volume":"130","author":"KA Sporer","year":"1999","unstructured":"Sporer KA. Acute heroin overdose. Ann Intern Med. 1999;130:584\u201390.","journal-title":"Ann Intern Med"},{"key":"6022_CR6","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1136\/emj.2003.009613","volume":"22","author":"SF Clarke","year":"2005","unstructured":"Clarke SF, Dargan PI, Jones AL. Naloxone in opioid poisoning: walking the tightrope. Emerg Med J. 2005;22:612\u20136.","journal-title":"Emerg Med J"},{"key":"6022_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/15563650.2016.1253846","volume":"55","author":"MW Willman","year":"2017","unstructured":"Willman MW, Liss DB, Schwarz ES, Mullins ME. Do heroin overdose patients require observation after receiving naloxone? Clin Toxicol. 2017;55:81\u20137.","journal-title":"Clin Toxicol"},{"key":"6022_CR8","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1080\/15563650.2018.1478093","volume":"56","author":"NC Stam","year":"2018","unstructured":"Stam NC, Pilgrim JL, Drummer OH, Smith K, Gerostamoulos D. Catch and release: evaluating the safety of non-fatal heroin overdose management in the out-of-hospital environment. Clin Toxicol. 2018;56:1135\u201342.","journal-title":"Clin Toxicol"},{"key":"6022_CR9","unstructured":"The Norwegian Institute of Public Health [Folkehelseinstituttet]. Drugs in Norway [Narkotika i Norge]. Folkehelseinstituttet. 2019. https:\/\/www.fhi.no\/nettpub\/narkotikainorge\/. Accessed 4 Apr 2020."},{"key":"6022_CR10","first-page":"646","volume":"141","author":"JV Tran","year":"2021","unstructured":"Tran JV, Brekke M, Vallersnes OM. Poisonings by substances of abuse at the Oslo Accident and Emergency Outpatient Clinic 2014\u201318. Tidsskr Nor Legeforen. 2021;141:646\u201351.","journal-title":"Tidsskr Nor Legeforen"},{"key":"6022_CR11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3109\/15563650.2014.898771","volume":"52","author":"DM Wood","year":"2014","unstructured":"Wood DM, Heyerdahl F, Yates CB, Dines AM, Giraudon I, Hovda KE, et al. The European Drug Emergencies Network (Euro-DEN). Clin Toxicol. 2014;52:239\u201341.","journal-title":"Clin Toxicol"},{"key":"6022_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13049-016-0268-6","volume":"24","author":"OM Vallersnes","year":"2016","unstructured":"Vallersnes OM, Jacobsen D, Ekeberg O, Brekke M. Outpatient treatment of acute poisoning by substances of abuse: a prospective observational cohort study. Scand J Trauma Resusc Emerg Med. 2016;24:76.","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"6022_CR13","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1517\/14740338.2015.1037274","volume":"14","author":"HK Kim","year":"2015","unstructured":"Kim HK, Nelson LS. Reducing the harm of opioid overdose with the safe use of naloxone: a pharmacologic review. Expert Opin Drug Saf. 2015;14:1137\u201346.","journal-title":"Expert Opin Drug Saf"},{"key":"6022_CR14","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1080\/15563650.2017.1312002","volume":"55","author":"OM Vallersnes","year":"2017","unstructured":"Vallersnes OM, Persett PS, Oiestad EL, Karinen R, Heyerdahl F, Hovda KE. Underestimated impact of novel psychoactive substances: laboratory confirmation of recreational drug toxicity in Oslo. Norway Clin Toxicol. 2017;55:636\u201344.","journal-title":"Norway Clin Toxicol"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-022-06022-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-022-06022-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-022-06022-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T08:08:22Z","timestamp":1649491702000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-022-06022-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,9]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6022"],"URL":"https:\/\/doi.org\/10.1186\/s13104-022-06022-2","relation":{},"ISSN":["1756-0500"],"issn-type":[{"type":"electronic","value":"1756-0500"}],"subject":[],"published":{"date-parts":[[2022,4,9]]},"assertion":[{"value":"24 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was done as part of a quality improvement study, commissioned by the director of the Department of Emergency General Practice at the OAEOC and by the head of the Department of Acute Medicine at the Oslo University Hospital (OUH), as per the Norwegian Law on Health Personnel \u00a726. The OUH Information Security and Privacy Office (ref no 2013\/3706) assessed the study to be a quality improvement study. Hence the need for approval by an ethics committee was waived by the Norwegian ethics committee regulations for quality improvement studies. The need for informed consent from the patients was also waived by the Norwegian ethics committee regulations for quality improvement studies. Data were registered anonymously from electronic medical records. The study was performed in accordance with guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"134"}}